Contributions
Abstract: EP1389
Type: ePoster
Abstract Category: Clinical aspects of MS - Clinical assessment tools
Background: Multiple Sclerosis (MS) is a chronic inflammatory neurological disease often leading to disability and requiring long-term disease-modifying treatment (DMT). Between currently available DMTs, there are vast differences in terms of both efficacy and risk profile.
In order to provide the patient with the optimal individual therapeutic option, a physician has to consider not only the disease course and a DMT"s benefit-risk-profile type, but also the patient"s individual characteristics such as personality, risk attitude and coping strategies. These characteristics are difficult to objectify in a routine medical investigation without the appropriate instruments.
Methods: In order to ensure patient"s adherence and treatment outcome, our goal was to assemble an objective test battery measuring an individual patient"s personality, risk attitude and coping strategies. For this aim, we administered established questionnaires on each of these dimensions to 22 consecutive MS patients of our MS outpatient clinic to determine their feasibility in MS-patients and examine possible differences to the healthy population. We used the German versions of the Big-Five-Personality Test for personality, the UPPS Impulsive Behavior Scale and the Domain-Specific Risk-Taking scale (DOSPERT) for risk attitude, the Brief-COPE and the Stress & Coping Inventory (SCI) for coping, and additionally the Beck Depression Inventory (BDI) for screening depression.
Results: Out of the 22 MS patients (7 males, 15 females) participating in this study, 19 (86.4%) completed all questionnaires. The mean age was 42.3 years (min-max range: 23-57), mean disease duration was 7.1 years (min-max range: 1-19). The median completion time was 45 minutes (min-max range: 25-60 min). The median scores of MS patients were in the average range of the published control sample in all questionnaires, with the only exception for a single subscale of the DOSPERT.
Conclusions: We report that traits of personality, risk attitude and coping can be effectively and feasibly tested in MS patients by the instruments used in our study. We, thus, believe that after validation in a larger cohort a battery consisting of the Big-Five-Personality Test, the UPPS Impulsive Behavior Scale and the Brief-COPE may be useful in shared-decision-making processes in routine practice.
Disclosure: All authors report that they have nothing to disclose.
Abstract: EP1389
Type: ePoster
Abstract Category: Clinical aspects of MS - Clinical assessment tools
Background: Multiple Sclerosis (MS) is a chronic inflammatory neurological disease often leading to disability and requiring long-term disease-modifying treatment (DMT). Between currently available DMTs, there are vast differences in terms of both efficacy and risk profile.
In order to provide the patient with the optimal individual therapeutic option, a physician has to consider not only the disease course and a DMT"s benefit-risk-profile type, but also the patient"s individual characteristics such as personality, risk attitude and coping strategies. These characteristics are difficult to objectify in a routine medical investigation without the appropriate instruments.
Methods: In order to ensure patient"s adherence and treatment outcome, our goal was to assemble an objective test battery measuring an individual patient"s personality, risk attitude and coping strategies. For this aim, we administered established questionnaires on each of these dimensions to 22 consecutive MS patients of our MS outpatient clinic to determine their feasibility in MS-patients and examine possible differences to the healthy population. We used the German versions of the Big-Five-Personality Test for personality, the UPPS Impulsive Behavior Scale and the Domain-Specific Risk-Taking scale (DOSPERT) for risk attitude, the Brief-COPE and the Stress & Coping Inventory (SCI) for coping, and additionally the Beck Depression Inventory (BDI) for screening depression.
Results: Out of the 22 MS patients (7 males, 15 females) participating in this study, 19 (86.4%) completed all questionnaires. The mean age was 42.3 years (min-max range: 23-57), mean disease duration was 7.1 years (min-max range: 1-19). The median completion time was 45 minutes (min-max range: 25-60 min). The median scores of MS patients were in the average range of the published control sample in all questionnaires, with the only exception for a single subscale of the DOSPERT.
Conclusions: We report that traits of personality, risk attitude and coping can be effectively and feasibly tested in MS patients by the instruments used in our study. We, thus, believe that after validation in a larger cohort a battery consisting of the Big-Five-Personality Test, the UPPS Impulsive Behavior Scale and the Brief-COPE may be useful in shared-decision-making processes in routine practice.
Disclosure: All authors report that they have nothing to disclose.